Tag Archive: ACS

Aug 14

The results are reported in the Journal of the American College of Cardiology.

The identification of high–risk plaque features using noninvasive CT imaging is a useful and independent predictor of acute coronary syndrome (ACS) in patients presenting to emergency departments with acute chest pain. According to findings from a substudy of the Rule Out Myocardial Infarction/Ischemia Using Computer–Assisted Tomography II (ROMICAT–II) trial, the presence of high–risk plaque features …

Continue reading »

Jul 28

The revised guidance from the National Institute for Health and Care Excellence (NICE)

The revised guidance from the National Institute for Health and Care Excellence (NICE) recommends once–daily, oral antiplatelet prasugrel, in combination with aspirin, as a cost–effective option in comparison to generic clopidogrel, for a wider group of acute coronary syndrome (ACS) patients having primary or delayed percutaneous coronary intervention (PCI).

Jul 20

Among patients who have acute chest pain but have a negative initial ECG or troponin test

Among patients who have acute chest pain but have a negative initial ECG or troponin test, a coronary computed–tomography CT angiography (CCTA) scan that detects high–risk plaque features can successfully identify those at higher risk of impending ACS, suggests a study presented at the Society of Cardiovascular Computed Tomography 2014 Annual Scientific Meeting.

May 12

A report published online in Nature Reviews Cardiology has put forward some new signs on coronary computed–tomography angiography (CCTA)

A report published online in Nature Reviews Cardiology has put forward some new signs on coronary computed–tomography angiography (CCTA) that can help identify coronary plaques at risk of rupture. Authors suggested that low CT attenuation, positive remodeling, and the napkin–ring sign indicate 5– to 20–fold increase in the risk of suffering ACS.

May 07

A new study has shown that an HDL mimetic used in the treatment of patients with ACS could not reduce the burden of atherosclerotic disease

A new study has shown that an HDL mimetic used in the treatment of patients with ACS could not reduce the burden of atherosclerotic disease. The findings are published online in the European Heart Journal.